How must the Tillomed Laboratories Ltd foscarnet sodium 24 mg/ml solution for infusion product be diluted for peripheral intravenous administration?

For peripheral intravenous administration, individually dispensed doses of the Tillomed Laboratories Ltd foscarnet sodium 24 mg/ml solution for infusion product must be aseptically transferred and diluted by the hospital pharmacy with an equal volume of 0.9% sodium chloride (9 mg/ml) or 5% glucose (50 mg/ml), then used promptly or refrigerated for up to 24 hours.